CFI-400945 in Patients With Advanced/Metastatic Breast Cancer

NCT03624543 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

51

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: CFI-400945

Sponsor

Canadian Cancer Trials Group

Collaborators

[object Object]